An innovative clinical trial is set to commence in Australia testing whether a common blood thinning drug can prevent SARS-CoV-2 infection. The drug is administered by nasal spray and researchers believe it can block the virus from initially infecting cells in the nose.
Category: Health & Wellbeing, Lifestyle
Tags: Coronavirus (COVID-19), New Atlas Audio
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.